Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints, Achieving Highest Complete Remission Rate of Any Global Lupus Nephritis Study admin March 1, 2017 Portfolio News, Aurinia Pharmaceuticals Learn More-External Link Back